» Articles » PMID: 12049739

C-Myc Can Induce DNA Damage, Increase Reactive Oxygen Species, and Mitigate P53 Function: a Mechanism for Oncogene-induced Genetic Instability

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2002 Jun 7
PMID 12049739
Citations 414
Authors
Affiliations
Soon will be listed here.
Abstract

Oncogene overexpression activates p53 by a mechanism posited to involve uncharacterized hyperproliferative signals. We determined whether such signals produce metabolic perturbations that generate DNA damage, a known p53 inducer. Biochemical, cytological, cell cycle, and global gene expression analyses revealed that brief c-Myc activation can induce DNA damage prior to S phase in normal human fibroblasts. Damage correlated with induction of reactive oxygen species (ROS) without induction of apoptosis. Deregulated c-Myc partially disabled the p53-mediated DNA damage response, enabling cells with damaged genomes to enter the cycle, resulting in poor clonogenic survival. An antioxidant reduced ROS, decreased DNA damage and p53 activation, and improved survival. We propose that oncogene activation can induce DNA damage and override damage controls, thereby accelerating tumor progression via genetic instability.

Citing Articles

Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment.

Espin R, Medina-Jover F, Siguenza-Andrade J, Farran-Matas S, Mateo F, Figueras A NAR Cancer. 2025; 7(1):zcaf007.

PMID: 40061566 PMC: 11886861. DOI: 10.1093/narcan/zcaf007.


Intratumour oxidative hotspots provide a niche for cancer cell dissemination.

Ueda Y, Kiyonaka S, Selfors L, Inoue K, Harada H, Doura T Nat Cell Biol. 2025; 27(3):530-543.

PMID: 39984655 DOI: 10.1038/s41556-025-01617-w.


TRIP13 protects pancreatic cancer cells against intrinsic and therapy-induced DNA replication stress.

Anand J, Droby G, Joseph S, Patel U, Zhang X, Klomp J bioRxiv. 2025; .

PMID: 39975297 PMC: 11838190. DOI: 10.1101/2025.01.26.634889.


Role of Oxidative Stress in the Occurrence, Development, and Treatment of Breast Cancer.

Dong R, Wang J, Guan R, Sun J, Jin P, Shen J Antioxidants (Basel). 2025; 14(1).

PMID: 39857438 PMC: 11760893. DOI: 10.3390/antiox14010104.


Gut microbiota derived metabolite trimethylamine N-oxide influences prostate cancer progression via the p38/HMOX1 pathway.

Zhou Y, Lv J, Jin S, Fu C, Liu B, Shen Y Front Pharmacol. 2025; 15():1526051.

PMID: 39850572 PMC: 11754881. DOI: 10.3389/fphar.2024.1526051.